+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Effects of alcohol consumption on eight circulating markers of liver fibrosis



Effects of alcohol consumption on eight circulating markers of liver fibrosis



Alcohol and Alcoholism 37(3): 252-255



A number of circulating breakdown products of collagen or other components of extracellular matrix, matrix degrading metalloproteinases (MMPs) and their tissue inhibitors (TlMPs) have been proposed as markers of hepatic fibrosis. However, the published results lack consistency. Since many of the patients with fibrosis studied were alcoholics, the question was raised whether recent alcohol consumption may affect the results obtained. Using sandwich-type assays of radioimmunoassay technology with corresponding antibodies, we studied eight markers of liver fibrosis: laminin, tenascin, undulin, TIMP-1, collagen VI, procollagen type III (PIIINP), hyaluronic acid (HA) and MMP-2. A group of 10 alcoholics was studied after significant alcohol consumption and following 2 weeks of abstinence, verified with repeated breath alcohol measurement. Laminin was significantly reduced at 1 week (22%) and at 2 weeks (30%). Similarly, tenascin and undulin were also significantly decreased. By contrast, TIMP-1, collagen VI, PIIINP, HA and MMP-2 did not significantly change. The mode of action of alcohol on these tests is unknown. These differences must be considered when using those measurements to assess liver fibrosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 010544832

Download citation: RISBibTeXText

PMID: 12003913

DOI: 10.1093/alcalc/37.3.252


Related references

Effects of alcohol intoxication on eight circulating markers of fibrosis. Gastroenterology 116(4 PART 2): A1263, April, 1999

Alcohol consumption and circulating markers of inflammation. Recenti Progressi in Medicina 96(2): 102-107, 2005

Circulating markers of liver fibrosis progression. Clinica Chimica Acta; International Journal of Clinical Chemistry 411(15-16): 1009-1017, 2010

Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. Journal of Hepatology 61(6): 1434-1437, 2015

Effect of alcohol withdrawal on liver transaminase levels and markers of liver fibrosis. Journal of Gastroenterology & Hepatology 16(11): 1254-1259, November, 2001

Effect of alcohol withdrawal on liver transaminase levels and markers of liver fibrosis. Journal of Gastroenterology and Hepatology 16(11): 1254-1259, 2002

Effect of abrupt alcohol withdrawal on liver transaminases and markers of liver fibrosis. Gut 40(SUPPL 1): A18, 1997

Biological alcohol markers. Genetic markers for familial alcoholism and markers for the detection of harmful alcohol consumption. Nordisk Medicin 107(6-7): 175-176, 1992

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 47(2): 455-460, 2007

Serum markers of liver fibrosis in patients with chronic hepatitis C infection. Prognostic value of noninvasive markers of fibrosis in liver transplantation. Gastroenterologia Y Hepatologia 35 Suppl 2: 17-22, 2013

Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clinica Chimica Acta 316(1-2): 71-81, February, 2002

Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clinica Chimica Acta; International Journal of Clinical Chemistry 316(1-2): 71-81, 2001

Circulating markers of oxidative stress and liver fibrosis in Sudanese subjects at risk of schistosomiasis and hepatitis. Acta Tropica 94(2): 99-106, 2005

Liver cirrhosis mortality, alcohol consumption and tobacco consumption over a 62 year period in a high alcohol consumption country: a trend analysis. Bmc Research Notes 8(): 822-822, 2016

Increased circulating level of dilinoleoylphosphatidylcholine is associated with protection against alcohol induced oxidative stress and liver fibrosis in man. Hepatology 32(4 Pt 2): 386A, October, 2000